About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
Baby Boomers face rising medical costs. At the same time, Medicare is growing, and taking up a greater share of the federal budget. While the Trump administration and Congress consider changes to Medicare, how can we keep costs in line, while also giving older Americans the care they need? The Atlantic gathered government officials, healthcare experts, and patient advocates to discuss the path forward for Medicare.
Where
The Newseum, 8th Floor
555 Pennsylvania Avenue, NW
Washington, DC
When
Wednesday, May 8, 2019
8:30-10:15AM
Speakers
- Sarah Dash, president and CEO, Alliance for Health Policy
- Matt Eyles, CEO, America’s Health Insurance Plans
- Liz Fowler, vice president, Global Health Policy, Johnson & Johnson
- Kathleen Koch, author and journalist
- Senator Jeff Merkley (D-OR), member, United States Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies
- Tricia Neuman, senior vice president and director, Program on Medicare Policy, Kaiser Family Foundation
- Vann R. Newkirk, staff writer, The Atlantic
- John O’Brien, senior advisor for drug pricing reform, U.S. Department of Health and Human Services
- Tara O’Neill Hayes, deputy director, Health Care Policy, American Action Forum
- Frederic Riccardi, president, Medicare Rights Center
- Zirui Song, assistant professor of health care policy and medicine, Harvard Medical School
- Stephen J. Ubl, president and CEO, PhRMA
- Gail Wilensky, senior fellow, Project HOPE
Resource
Medicare
The State of Care: Future of Medicare
The State of Care: Future of Medicare image